Recombinant multi-species Brevican/BCAN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Brevican/BCAN protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the lectican family of chondroitin sulfate proteoglycans that is specifically expressed in the central nervous system. This protein is developmentally regulated and may function in the formation of the brain extracellular matrix. This protein is highly expressed in gliomas and may promote the growth and cell motility of brain tumor cells. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2011]
The Alternative Names of target: ALPBRE,BCAN,BEHAB,Bcan,Brain-enriched hyaluronan-binding protein (BEHAB),Brevican,Brevican core protein,CSPG7,Chondroitin sulfate proteoglycan 7,Cspg7

Target products collectionGo to Brevican/BCAN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0044-Ag-1/ GM-Tg-hg-SE0044-Ag-2 Human Brevican/BCAN protein Human
GM-Tg-rg-SE0044-Ag-1/ GM-Tg-rg-SE0044-Ag-2 Rat Brevican/BCAN protein Rat
GM-Tg-mg-SE0044-Ag-1/ GM-Tg-mg-SE0044-Ag-2 Mouse Brevican/BCAN protein Mouse
GM-Tg-cynog-SE0044-Ag-1/ GM-Tg-cynog-SE0044-Ag-2 Cynomolgus/Rhesus macaque Brevican/BCAN protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0044-Ag-1/ GM-Tg-felg-SE0044-Ag-2 Feline Brevican/BCAN protein Feline
GM-Tg-cang-SE0044-Ag-1/ GM-Tg-cang-SE0044-Ag-2 Canine Brevican/BCAN protein Canine
GM-Tg-bovg-SE0044-Ag-1/ GM-Tg-bovg-SE0044-Ag-2 Bovine Brevican/BCAN protein Bovine
GM-Tg-equg-SE0044-Ag-1/ GM-Tg-equg-SE0044-Ag-2 Equine Brevican/BCAN protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0044-Ag-1/ GM-Tg-hg-SE0044-Ag-2; GM-Tg-rg-SE0044-Ag-1/ GM-Tg-rg-SE0044-Ag-2;
GM-Tg-mg-SE0044-Ag-1/ GM-Tg-mg-SE0044-Ag-2; GM-Tg-cynog-SE0044-Ag-1/ GM-Tg-cynog-SE0044-Ag-2;
GM-Tg-felg-SE0044-Ag-1/ GM-Tg-felg-SE0044-Ag-2; GM-Tg-cang-SE0044-Ag-1/ GM-Tg-cang-SE0044-Ag-2;
GM-Tg-bovg-SE0044-Ag-1/ GM-Tg-bovg-SE0044-Ag-2; GM-Tg-equg-SE0044-Ag-1/ GM-Tg-equg-SE0044-Ag-2
Products Name Brevican/BCAN protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Brevican/BCAN
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Brevican/BCAN protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.